Nachum Kaplan

988 total citations
21 papers, 724 citations indexed

About

Nachum Kaplan is a scholar working on Infectious Diseases, Molecular Biology and Molecular Medicine. According to data from OpenAlex, Nachum Kaplan has authored 21 papers receiving a total of 724 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 11 papers in Molecular Biology and 7 papers in Molecular Medicine. Recurrent topics in Nachum Kaplan's work include Antimicrobial Resistance in Staphylococcus (11 papers), Bacterial biofilms and quorum sensing (7 papers) and Antibiotic Resistance in Bacteria (7 papers). Nachum Kaplan is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (11 papers), Bacterial biofilms and quorum sensing (7 papers) and Antibiotic Resistance in Bacteria (7 papers). Nachum Kaplan collaborates with scholars based in United States, Israel and Canada. Nachum Kaplan's co-authors include Eugene Rosenberg, Barry Hafkin, Zinaida Zosim, Molly B. Schmid, Brian S. Murphy, Daryl J. Hoban, Judd Berman, Henry W. Pauls, George G. Zhanel and Donald E. Awrey and has published in prestigious journals such as Applied and Environmental Microbiology, Antimicrobial Agents and Chemotherapy and European Journal of Biochemistry.

In The Last Decade

Nachum Kaplan

21 papers receiving 673 citations

Peers

Nachum Kaplan
Maria Laura Ciusa United Kingdom
George P. Dinos Greece
Timothy R. Kane Canada
Varsha Gupta India
Parjit Kaur United States
Bryan D. Schindler United States
Elizabeth Peterson United States
Shannon B. Falconer Canada
Elizabeth M. Darby United Kingdom
Freshteh Toghrol United States
Maria Laura Ciusa United Kingdom
Nachum Kaplan
Citations per year, relative to Nachum Kaplan Nachum Kaplan (= 1×) peers Maria Laura Ciusa

Countries citing papers authored by Nachum Kaplan

Since Specialization
Citations

This map shows the geographic impact of Nachum Kaplan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nachum Kaplan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nachum Kaplan more than expected).

Fields of papers citing papers by Nachum Kaplan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nachum Kaplan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nachum Kaplan. The network helps show where Nachum Kaplan may publish in the future.

Co-authorship network of co-authors of Nachum Kaplan

This figure shows the co-authorship network connecting the top 25 collaborators of Nachum Kaplan. A scholar is included among the top collaborators of Nachum Kaplan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nachum Kaplan. Nachum Kaplan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hunt, Thomas L., Nachum Kaplan, & Barry Hafkin. (2015). Safety, tolerability and pharmacokinetics of multiple oral doses of AFN-1252 administered as immediate release (IR) tablets in healthy subjects. Journal of Chemotherapy. 28(3). 164–171. 9 indexed citations
2.
Flamm, Robert K., Paul R. Rhomberg, Nachum Kaplan, Ronald N. Jones, & David J. Farrell. (2015). Activity of Debio1452, a FabI Inhibitor with Potent Activity against Staphylococcus aureus and Coagulase-Negative Staphylococcus spp., Including Multidrug-Resistant Strains. Antimicrobial Agents and Chemotherapy. 59(5). 2583–2587. 25 indexed citations
3.
Hafkin, Barry, Nachum Kaplan, & Thomas L. Hunt. (2015). Safety, Tolerability and Pharmacokinetics of AFN–1252 Administered as Immediate Release Tablets in Healthy Subjects. Future Microbiology. 10(11). 1805–1813. 13 indexed citations
4.
5.
6.
Banevicius, Mary Anné, Nachum Kaplan, Barry Hafkin, & David P. Nicolau. (2013). Pharmacokinetics, pharmacodynamics and efficacy of novel FabI inhibitor AFN-1252 against MSSA and MRSA in the murine thigh infection model. Journal of Chemotherapy. 25(1). 26–31. 37 indexed citations
7.
Kaplan, Nachum, Colin Garner, & Barry Hafkin. (2013). AFN-1252 in vitro absorption studies and pharmacokinetics following microdosing in healthy subjects. European Journal of Pharmaceutical Sciences. 50(3-4). 440–446. 27 indexed citations
8.
Kaplan, Nachum, Donald E. Awrey, Judd Berman, et al.. (2013). In vitroactivity (MICs and rate of kill) of AFN-1252, a novel FabI inhibitor, in the presence of serum and in combination with other antibiotics. Journal of Chemotherapy. 25(1). 18–25. 29 indexed citations
9.
Parsons, Joshua B., Pamela Jackson, Mark Pulse, et al.. (2013). Perturbation of Staphylococcus aureus Gene Expression by the Enoyl-Acyl Carrier Protein Reductase Inhibitor AFN-1252. Antimicrobial Agents and Chemotherapy. 57(5). 2182–2190. 29 indexed citations
10.
Kaplan, Nachum, Monique Albert, Donald E. Awrey, et al.. (2012). Mode of Action, In Vitro Activity, and In Vivo Efficacy of AFN-1252, a Selective Antistaphylococcal FabI Inhibitor. Antimicrobial Agents and Chemotherapy. 56(11). 5865–5874. 92 indexed citations
11.
Sampson, Peter B., Christine J. Picard, Andrew Leeson, et al.. (2009). Spiro-naphthyridinone piperidines as inhibitors of S. aureus and E. coli enoyl-ACP reductase (FabI). Bioorganic & Medicinal Chemistry Letters. 19(18). 5355–5358. 17 indexed citations
12.
Karlowsky, James A., Nachum Kaplan, Barry Hafkin, Daryl J. Hoban, & George G. Zhanel. (2009). AFN-1252, a FabI Inhibitor, Demonstrates a Staphylococcus-Specific Spectrum of Activity. Antimicrobial Agents and Chemotherapy. 53(8). 3544–3548. 66 indexed citations
13.
Ramnauth, Jailall, Peter B. Sampson, Emily Freeman, et al.. (2009). 2,3,4,5-Tetrahydro-1H-pyrido[2,3-b and e][1,4]diazepines as inhibitors of the bacterial enoyl ACP reductase, FabI. Bioorganic & Medicinal Chemistry Letters. 19(18). 5359–5362. 19 indexed citations
14.
Kaplan, Nachum. (2003). Use of thermonuclease testing to identify Staphylococcus aureus by direct examination of blood cultures. Eastern Mediterranean Health Journal. 9(1-2). 185–190. 3 indexed citations
15.
Kaplan, Nachum, et al.. (2003). Microbiology of wound infection after caesarean section in a Jordanian hospital. Eastern Mediterranean Health Journal. 9(5-6). 1068–1074. 16 indexed citations
16.
Rosenberg, Mel, et al.. (1995). DNA fromSerratia marcescensconfers a hydrophobic character inEscherichia coli. FEMS Microbiology Letters. 125(1). 71–75. 2 indexed citations
17.
Kaplan, Nachum, Zinaida Zosim, & Eugene Rosenberg. (1987). Reconstitution of emulsifying activity of Acinetobacter calcoaceticus BD4 emulsan by using pure polysaccharide and protein. Applied and Environmental Microbiology. 53(2). 440–446. 69 indexed citations
18.
Kaplan, Nachum, Eugene Rosenberg, Barbara Jann, & Klaus Jann. (1985). Structural studies of the capsular polysaccharide of Acinetobacter calcoaceticus BD4. European Journal of Biochemistry. 152(2). 453–458. 46 indexed citations
19.
Rosenberg, Eugene, Nachum Kaplan, Ophry Pines, Mel Rosenberg, & David L. Gutnick. (1983). Capsular polysaccharides interfere with adherence ofAcinetobacter calcoaceticusto hydrocarbon. FEMS Microbiology Letters. 17(1-3). 157–160. 59 indexed citations
20.
Kaplan, Nachum & Eugene Rosenberg. (1982). Exopolysaccharide Distribution of and Bioemulsifier Production by Acinetobacter calcoaceticus BD4 and BD413. Applied and Environmental Microbiology. 44(6). 1335–1341. 101 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Laura Ciusa Breakdown of academic impact, for papers by George P. Dinos Breakdown of academic impact, for papers by Timothy R. Kane Breakdown of academic impact, for papers by Varsha Gupta Breakdown of academic impact, for papers by Parjit Kaur Breakdown of academic impact, for papers by Bryan D. Schindler Breakdown of academic impact, for papers by Elizabeth Peterson Breakdown of academic impact, for papers by Shannon B. Falconer Breakdown of academic impact, for papers by Elizabeth M. Darby Breakdown of academic impact, for papers by Freshteh Toghrol
Rankless by CCL
2026